2224 ⎘
Animals characterised by purpose; Animal model, e.g. for test or diseases; Animal model for multifactorial diseases Animal model for inflammation
MOUSE MODEL OF DITRA DISEASE AND USES THEREOF
#2ZEBRAFISH ANIMAL MODEL FOR INFLAMMATORY DISEASES AND METHOD FOR SCREEING ANTI-INFLAMMATORY AGENTS USING SAME
#3COMPOSITION
#4GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
#5COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING ALZHEIMER'S DISEASE
#6COMPOSITION FOR TREATING OR PREVENTING IMMUNOLOGICAL ABNORMAL INFLAMMATORY DISEASES
#7IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#8IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#9MOUSE MODEL FOR BIO-IMAGING OF INFLAMMATORY SIGNALS, PREPARATION METHOD THEREFOR AND USE THEREOF
#10Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids
#11METHOD FOR PRODUCING AVATAR MOUSE AS ATOPIC DERMATITIS ANIMAL MODEL AND USE THEREOF
#12MOUSE MODEL OF DITRA DISEASE AND USES THEREOF
#13Humanized IL-4 and IL-4Rα animals
#14GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC IL33
#15ANIMAL MODEL FOR DRUG DEVELOPMENT
#16NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX
#17Humanized IL-4 and IL-4Rα animals
#18CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION
#19VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
#20loss of function rodent model
#21METHODS AND COMPOSITIONS FOR MODULATING INNATE LYMPHOID CELL PATHOGENIC EFFECTORS
#22Method for producing disease modeling non-human animal, disease modeling non-human animal, and method for screening drug and method for determining risk of disease using the same
#23Humanized C5 animals
#24Humanized IL-4 and IL-4Ra animals
#25Mouse model of DITRA disease and uses thereof
#26Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH
#27ANIMAL MODEL FOR DRUG DEVELOPMENT
#28ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA
#29MARKER FOR PREDICTING PRESSURE ULCER DEVELOPMENT AND USE THEREOF
#30Non-human animals expressing humanized C1Q complex
#31CD31 as a molecular target for imaging of inflammation
#32Antibodies to oxidized phospholipids
#33Antibodies to oxidized phospholipids
#34Humanized C3 animals
#35Application of PCSK9 inhibitors in the preparation of drugs for the treatment of inflammatory immune diseases
#36Model animal for fibrosis
#37Antibodies to oxidized phospholipids
#38NON-HUMAN MAMMAL
#39Humanized model of kidney and liver disorders
#40MODELS, METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE
#41IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#42Method for reducing the inflammatory activity of a stem cell transplant and use thereof
#43Humanized IL-4 and IL-4Rα animals
#44ADAM12 inhibitors and their use against inflammation-induced fibrosis
#45Humanized C5 animals
#46Humanized IL-4 and IL-4Rα animals
#47Inflammation reporter system
#48Transgenic mouse expressing kidney-specific human TGF-beta1, and biomarker for tissue fibrosis mouse model
#49Method of genetically altering and producing allergy free cats
#50Transgenic non-human mammal that expresses human MMP2
#51Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema
#52Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH
#53Non-human animals having a disruption in a C9ORF72 locus
#54Method for reducing the inflammatory activity of a stem cell transplant and use thereof
#55Transgenic mice expressing human pyrin domain only protein 2
#56Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease
#57Atopic dermatitis model animal and use thereof
#58Transgenic model for delay-type hypersensitivity (DTH) and use thereof
#59ANIMAL MODEL WITH A FILAGGRIN GENE PROMOTER
#60Humanized IL-4 and IL-4Ra animals
#61Humanized IL-4 and IL-4Rα animals
#62Humanized C3 animals
#63HUMANIZED TRANSGENIC SINGLE NUCLEOTIDE POLYMORPHISM ANIMAL SYSTEMS
#64Obesity animal model and methods for making and using thereof
#65Use of antagonists targeting metallothionein to treat intestinal inflammation
#66TRANSGENIC MOUSE EXPRESSING HUMAN LIPOPROTEIN (A) WITH DISABLED VITAMIN C GENE AND ITS USE AS A DISEASE TREATMENT MODEL
#67Activity modulator, medicinal agent comprising same, use of CD300A gene-deficient mouse, and anti-CD300A antibody
#68Inflammation in vivo model
#69TL1A model of inflammation fibrosis and autoimmunity
#70ADAM12 inhibitors and their use against inflammation-induced fibrosis
#71Method of treating pulmonary disease by administering an antibody to G-CSF
#72Methods and uses of TIE2 binding and/or activating agents
#73ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
#74NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS
#75Transgenic mouse conditionally expressing MMP12 for studying myelopoiesis, immunity and tumorigenesis
#76Method of Genetically Altering and Producing Allergy Free Cats
#77Compositions And Methods Of Inhibiting NADPH Oxidase Expression
#78KNOCK-IN MICE WITH INDUCIBLE LOSS OF EOSINOPHILS
#79TL1A model of inflammation fibrosis and autoimmunity
#80Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
#81Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
#82Methods concerning PPAR delta and antagonists thereof
#83Method for selective control of helper T cell function
#84COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS
#85IL-17 RECEPTOR LIKE MOLECULES AND USES THEREOF
#86Transgenic animal with monocyte chemotactic protein 1 promoter
#87knockout mice and elucidation of association of with early onset degenerative joint disease and role as a tumor suppressor
#88Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
#89Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH
#90GENOMIC EDITING OF GENES INVOLVED IN INFLAMMATION
#91TREATMENT OF FIBROSES AND LIVER DISORDERS
#92MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE QPCTL-GENE
#93METHOD OF SCREENING PTP ZETA ACTIVITY PROMOTER OR INHIBITOR
#94COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION
#95Properdin Modulation of Alternative Pathway and Uses Thereof
#96TRANSGENIC MICE EXPRESSING HUMAN FORMYL PEPTIDE RECEPTOR
#97RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#98METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION
#99METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#100Use of Tumor Necrosis Factor-Alpha P75 Receptor for the Reduction of Inflammation
#101Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
#102RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#103C-REACTIVE PROTEIN (CRP) KNOCKOUT MOUSE
#104PROTEIN FORMULATIONS COMPRISING S1-5
#105METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#106Method of treating pulmonary disease by administering an antibody to G-CSF receptor
#107COMPLEMENT INHIBITORY AGENTS AS THERAPEUTICS IN POSTTRAUMATIC AND DEGENERATIVE ARTHRITIS
#108Tl1a in treatment of disease
#109Method for producing antibodies
#110SGRF gene-modified mouse
#111IL-17 receptor like molecules and uses thereof
#112Characterization of a MEKK binding site and uses thereof
#113BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
#114CYR61 COMPOSITIONS AND METHODS
#115METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS & IMPAIRED LUNG FUNCTION & TO ENHANCE LYMPHOCYTE PRODUCTION
#116TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6
#117Deregulated Genes and/or Processes in Inflammatory Arthritis
#118DNA vaccine
#119Inflammation treatment, detection and monitoring via TREM-1
#120ANTAGONIZING INTERLEUKIN-21 RECEPTOR ACTIVITY
#121Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
#122Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2
#123Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity
#124Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)
#125CBG gene as a genetic marker of hypercortisolism and associated pathologies
#126Methods and compositions for inhibiting the function of polynucleotide sequences
#127Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
#128Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal
#129ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor
#130Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and use
#131Modulation of immune response and inflammation by targeting hypoxia inducible factors
#132Methods and compositions for inhibiting the function of polynucleotide sequences
#133Methods and compositions for inhibiting the function of polynucleotide sequences
#134Methods and compositions for inhibiting the function of polynucleotide sequences
#135Therapeutic agent for fibromyalgia
#136Vertebrate embryonic pattern-inducing proteins, and uses related thereto
#137BLOCKING LEUKOCYTE EMIGRATION AND INFLAMMATION BY INTERFERING WITH CD99/HEC2
#138Proton-sensing g-protein coupled receptors and dna sequences thereof
#139Method for screening PTPzeta activity promoter or inhibitor
#140Methods and compositions for in vivo inflammation monitoring
#141Mediators of epithelial adhesion and their role in cancer and skin disorders
#142Therapeutic agent for fibromyalgia
#143Method for identifying novel treatments of inflammatory disease in the gut
#144ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for
#145Nonbacterial prostatitis model animal
#146Methods and compositions for inhibiting the function of polynucleotide sequences
#147Antibodies for IL-17 receptor like polypeptides and uses thereof
#148IL-17 receptor like polypeptides and uses thereof
#149IL-receptor like molecules and uses thereof
#150Therapeutic agent for fibromyalgia
#151Transgenic mice containing chemokine receptor 9A gene disruptions
#152Antagonizing interleukin-21 receptor activity
#153Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
#154IRAK-4: compositions and methods of use
#155BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
#156Methods and compositions for inhibiting the function of polynucleotide sequences
#157IL-17 receptor like molecules and uses thereof
#158Compositions and methods for the treatment and diagnosis of immune disorders
#159P2x7 receptor-deficient non-human animals and uses thereof
#160Sgrf gene-modified non-human animals
#161Non-human mammal model of autoimmune disease having OX40L gene transferred thereinto
#162Animal model for allergy
#163Vertebrate embryonic pattern-inducing proteins and uses related thereto